Potential role of the compound Eucommia bone tonic granules in patients with osteoarthritis and osteonecrosis: A retrospective study

Table 3 Comparison of the WOMAC score in the two groups of osteoarthritis patients

Item	Time	Pain	Stiff	Dysfunction
Eucommia-meloxicam group	Before treatment	13.32 ± 2.12	5.23 ± 1.14	37.23 ± 3.21
	After treatment	6.23 ± 1.23	2.38 ± 1.06	23.35 ± 2.31
	t	21.266	5.544	69.158
	P	0.000	0.000	0.000
Meloxicam group	Before treatment	14.42 ± 2.46	6.16±1.27	36.32 ± 4.17
	After treatment	3.69 ± 0.37	1.85 ± 0.26	18.37 ± 3.52
	t	30.906	60.655	45.852
	P	0.000	0.000	0.000
Comparison of the two groups before treatment	t	9.179	4.418	4.876
	P	0.000	0.000	0.000
Comparison of the two groups after treatment	t	21.551	0.74	11.508
	P	0.000	0.469	0.000